Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04588298
Title A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer (SERENA-3)
Acronym SERENA-3
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Facility Status City State Zip Country Details
Research Site Batumi 6000 Georgia Details
Research Site Tbilisi '0112 Georgia Details
Research Site Tbilisi '0186 Georgia Details
Research Site Tbilisi 0159 Georgia Details
Research Site Tbilisi 0179 Georgia Details
Research Site Aguascalientes 20230 Mexico Details
Research Site Mexico City '14080 Mexico Details
Research Site Derby DE22 3NE United Kingdom Details
Research Site Leicester LE1 5WW United Kingdom Details
Research Site Liverpool L7 8XP United Kingdom Details
Research Site London W12 0HS United Kingdom Details
Research Site Manchester M23 9LT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field